Comparison

Gemcitabine monophosphate sodium salt hydrate European Partner

Item no. TMO-T4187-10mg
Manufacturer TargetMol
CASRN 1638288-31-9
Amount 10 mg
Quantity options 100 mg 10 mg 200 mg 25 mg 50 mg
Category
Type Molecules
Specific against other
Citations 1.Miao L, et al. Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer. Adv Funct Mater. 2014 Nov 12;24(42):6601-6611. PubMed PMID: 25395922; PubMed Central PMCID: PMC4225819.
Smiles O.[Na+].[Na+].Nc1ccn([C@@H]2O[C@H](COP([O-])([O-])=O)[C@@H](O)C2(F)F)c(=O)n1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias Autophagy,DNA Alkylation,DNA/RNA Synthesis,
Shipping Condition Cool pack
Available
Manufacturer - Targets
DNA|||DNA/RNA Synthesis|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
405.16
Description
Gemcitabine monophosphate disodium salt is a monophosphate derivative of Gemcitabine.
Pathways
DNA Damage/DNA Repair|||Cell Cycle/Checkpoint|||Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close